Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
Clinical trial NCT07567014 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07567014
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-11
- Primary completion
- 2028-05-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.